LABU News and Press, Direxion Daily S&P Biotech Bull 3X Shares From 04/01/23

2023-04-01 08:00:00 ET Summary Leveraged ETFs have an unpredictable behavior: explanation. A drift dashboard with 22 of them. A closer look at SPUU history. The Direxion Daily S&P 500 Bull 2X Shares ETF (SPUU) is an instrument magnifying the broad market performa...

Summary Leveraged ETFs may be unpredictable. A drift dashboard with 22 of them. A closer look at Direxion Daily S&P 500 Bull 3x Shares ETF history. The ProShares Direxion Daily S&P 500 Bull 3x Shares ETF ( SPXL ) is one of the most popular instruments to trade ...

Summary Some explanations about leveraged ETFs’ non-linear behavior. Leveraged ETFs in biotechnology and semiconductors show large drifts. SPXS 12-month drift became negative in April 2022 and has deteriorated since then. Lessons of SPXS history. This article ...

Summary Biotech stocks have pulled back and offer better risk to reward for investors, Direxion Daily S&P Biotech Bull 3x Shares ETF is a popular way to trade them. M&A is likely to drive prices for mid-cap and small-cap biopharma. Using a leveraged ETF like LABU is risky, e...

Summary Since 1927, the S&P 500 in January averages one of the most positive months of the year.  February averages the 2nd most negative month. The Fed has reiterated in December and the minutes released in January that at least three more rate hikes are planned for 2023 start...

Summary A table with the drifts of SDS and 21 other leveraged ETFs. Biotechnology leveraged ETFs have the worst monthly decay. The annual decay of SDS is close to zero on average, but it may be harmful for long periods of time. The ProShares UltraShort S&P 500 ETF ( ...

Summary Since July 8 when I rated LABD a SELL, the underlying biotechnology index has moved very little up or down; LABD declined 25.22%. The biotechnology sector has done relatively well during the last four months; it is expected to continue trading sideways. The 3x inverse ...

Summary Leveraged ETFs have a non-linear, unpredictable behavior. A drift dashboard with 22 of them. A closer look at one or the worst: LABD. For further details see: LABD: A Bad Bad Drift

Summary LABU is more volatile than unleveraged funds, due to its 3-times investments in the derivatives of stocks listed in its benchmark index. During the past 4 months, biotechnology stocks performed quite well, and this bull run has come during a period when the overall market ...

Summary Leveraged ETFs behavior is neither intuitive nor predictable. Below is a dashboard with 22 of them, including SPUU. LABD is the worst of the list. Focus on SPUU: drift history and comparison with UPRO. The Direxion Daily S&P 500 Bull 2X Shares ETF ( ...